Carcinoma‐associated fibroblasts derive from mesothelial cells via mesothelial‐to‐mesenchymal transition in peritoneal metastasis
Pilar Sandoval(Consejo Superior de Investigaciones Científicas), Manuel López‐Cabrera(Consejo Superior de Investigaciones Científicas), Raquel Ruz Reyes(Centro de Biología Molecular Severo Ochoa), María Luisa Pérez‐Lozano(Inserm), Javier Dotor(SOM Biotech (Spain)), Julio García‐Bordas(Hospital General Universitario Gregorio Marañón), Ángela Rynne‐Vidal(Centro de Biología Molecular Severo Ochoa), Pedro Majano(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Manuel Fresno(Hospital Universitario de La Princesa), Álvaro Gilsanz(Centro de Biología Molecular Severo Ochoa), José A. Jiménez‐Heffernan(Hospital Universitario de La Princesa), Carlos Cabañas(Centro de Biología Molecular Severo Ochoa), Konstantinos Stamatakis(Centro de Biología Molecular Severo Ochoa), Vicente Ruiz‐Carpio(Centro de Biología Molecular Severo Ochoa)
Cited by 183
Related Papers
Mesothelial‐to‐mesenchymal transition in the pathogenesis of post‐surgical peritoneal adhesions
|The Journal of Pathology|2016|119
Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-κB/Snail1 pathway
|Disease Models & Mechanisms|2008|118
Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
|The Journal of Pathology|2017|114
Caveolin‐1 deficiency induces a MEK‐ERK1/2‐Snail‐1‐dependent epithelial–mesenchymal transition and fibrosis during peritoneal dialysis
|EMBO Molecular Medicine|2014|92
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis
|Digestive and Liver Disease|2021|62